Questions about a product, technology or experimental design? Give us a call 610-644-8845.

SUMO-Tag Protein Expression & Purification

Protein expression and production of recombinant proteins routinely encounters problems, including formation of inclusion bodies, incorrect protein conformation, toxicity to the host cell, and low protein yield. These issues are most often addressed by using an alternative host or genetically fusing the protein of interest (POI) to a carrier protein (fusion tag). Attachment of the C-terminus of SUMO (Small Ubiquitin Like Modifier) to the N-terminus of a protein of interest can dramatically improve protein solubility, achieve native protein folding, and increase total yield by improving expression and decreasing degradation. LifeSensors protein expression system has pioneered SUMO fusion technology, which increases the quantity and quality of numerous recombinant proteins in both prokaryotic and eukaryotic expression hosts. We offer a protein expression service related to the expression and purification of proteins.

Our SUMO-tag expression system maximizes the yield of soluble, functional proteins in E. coli. SUMO functions as both a chaperonin and initiator of protein folding, improving the solubility and yield of your POI. De-sumoylases remove the SUMO tags, releasing your protein with the desired N-terminal amino acid. Both SUMO tags and de-sumoylases contain 6xHis tags allowing efficient subsequent removal, leaving pure protein.

The SUMOPro system is designed for expression and purification of proteins from E. coli. Since all eukaryotic cells contain SUMO and SUMO proteases, the latter of which will cleave SUMO-fusion proteins immediately following expression, LifeSensors has engineered SUMOstar, a SUMO tag for use in eukaryotic hosts, which is resistant to endogenous proteases, thus preserving enhanced expression, increased solubility and native folding. SUMOstar fusion proteins can be cleaved only with SUMOstar protease.

Bacterial

The SUMOpro tag system is based off our SUMO protein expression platform to maximize the yield of soluble and functional proteins with a native N-terminus. Precise tag removal relies on LifeSensors’ highly specific SUMO proteases, which recognize the tertiary structure of the tag at the N-terminus of the partner protein and cleaves the junction at discrete residues outside the protein sequence. Therefore, SUMO proteases are superior to other proteases commonly used in prokaryotic expression systems that may non-specifically cleave within the protein of interest or leave extra residues behind. By linking a His6 tag to both the SUMOpro fusion tag and SUMO protease, the system allows efficient and rapid purification of untagged proteins using immobilized metal affinity chromatography. SUMOpro fusion, thus, makes purifying your protein easy and affordable.

LifeSensors offers both yeast (SUMOpro) and human (SUMOpro3) tags with corresponding SUMO proteases 1 and 2, respectively.

Service Highlights

SUMOpro E.COLI

The SUMOpro tag system was developed from SUMO to maximize the yield of soluble and functional proteins with a native N-terminus. We can extend the benefits of our SUMOpro tag to mammalian hosts, increasing the expression and solubility of your protein while ensuring proper post-translational modifications (PTMs) within the cell. Precise tag removal relies on LifeSensors’ highly specific SUMO proteases, which recognizes the tertiary structure of the tag at the N-terminus of the partner protein and cleaves the junction at discrete residues outside the protein sequence.

LifeSensors offers both yeast (SUMOpro) and human (SUMOpro-3) tags with corresponding SUMO proteases 1 and 2, respectively, for mammalian expression. By linking a His6 tag to both the SUMOpro fusion tag and SUMO protease, the system allows efficient and rapid purification of untagged protein using immobilized metal affinity chromatography. SUMOpro fusion, thus, makes purifying your protein easy and affordable.

Related Products

Service Highlights

Advanced Therapeutic Applications

Many new therapies are now being delivered as genes, mRNA, or AAV-mediated vehicles. Poor expression in prokaryotic and eukaryotic hosts is the primary cause of a lack of efficacy of these therapies. Clinical-scale production of functional biotherapeutics such as proteins used in CAR-T therapy and vaccine candidates routinely faces challenges of expression quantity, misfolding, incorrect localization, degradation in the host cell, and HIGH costs. However, clinical-scale production remains critical for successful therapeutic outcomes.

To overcome these challenges, we developed the SUMOstar™ tag, a modified version of the SUMO fusion platform ideal for mammalian expression due to its resistance to endogenous SUMO proteases found in all eukaryotic systems. The SUMOstar™ tag remains tethered to the protein throughout the purification process. Precise C-terminal removal of the tag simply requires end user-induced cleavage by engineered SUMOstar™ proteases. The native N-terminal residues of the protein are completely preserved following cleavage, which is particularly important for researchers seeking biologically active cytokine-based therapeutic strategies.

Please contact us for additional information or a quote for expression services

Service Highlights